{
  "instance_id": 185,
  "chat_eval": "0",
  "answer": "ENSG00000142192",
  "extracted_solution_or_last_step": "# Genetic Analysis Report: Identification of Causal Gene\n\n## Executive Summary\n\nThis analysis identified **ENSG00000084234 (APLP2)** as the most likely causal gene responsible for the patient's complex neurological and vascular phenotype. The evidence strongly supports APLP2's role in cerebral thrombosis regulation, which directly explains the patient's thromboembolism-related symptoms.\n\n## Patient Phenotype Analysis\n\nThe patient presents with 15 distinct phenotypes (HP terms) that can be categorized as follows:\n\n**Primary Thrombotic Manifestations:**\n- HP:0002170: Thromboembolism\n- HP:0001297: Stroke\n- HP:0100659: Abnormal cerebral vascular morphology\n\n**Neurological Consequences:**\n- HP:0001336: Myoclonus\n- HP:0001268: Mental deterioration\n- HP:0002354: Memory impairment\n- HP:0001288: Gait disturbance\n- HP:0006897: Abducens palsy\n- HP:0000708: Atypical behavior\n\n**Additional Clinical Features:**\n- HP:0000400: Macrotia\n- HP:0001944: Dehydration\n- HP:0031909: Unicornuate uterus\n- HP:0003307: Hyperlordosis\n- HP:0025328: Antepartum hemorrhage\n- HP:0002085: Occipital encephalocele\n\n## Candidate Gene Analysis\n\n17 candidate genes were systematically evaluated from the provided ENSG list:\n\n| ENSG ID | Gene Symbol | Primary Function | Relevance |\n|---------|-------------|------------------|-----------|\n| ENSG00000084234 | **APLP2** | **Amyloid precursor-like protein 2** | **High** |\n| ENSG00000142192 | APP | Amyloid precursor protein | Medium |\n| ENSG00000166326 | TRIM44 | Tripartite motif protein | Low |\n| ENSG00000181027 | FKRP | Fukutin-related protein | Low |\n| ENSG00000273079 | GRIN2B | Glutamate receptor subunit | Low |\n\n## Key Evidence Supporting APLP2\n\n### Literature Evidence\n- Direct evidence from PubMed showing APLP2's role in cerebral thrombosis regulation [1]\n- Literature demonstrates that APLP2 family proteins regulate cerebral thrombosis through Kunitz serine proteinase inhibitors [2]\n- APLP2 is associated with chronic thromboembolic pulmonary hypertension [3]\n\n### Database Evidence (DisGeNET)\nAPLP2 appears in multiple thrombosis-related disorders:\n- Cerebral Thrombosis\n- Carotid Artery Thrombosis\n- Venous Thrombosis\n- Pulmonary Embolism\n\n### Biological Mechanism\nAPLP2 encodes amyloid precursor-like protein 2, which:\n- Functions as a Kunitz serine proteinase inhibitor\n- Regulates blood coagulation and fibrinolysis\n- Loss of function mutations can cause hypercoagulable states\n- Directly explains thromboembolism and cerebral vascular abnormalities\n\n## Clinical Correlation\n\nThe patient's phenotype pattern is consistent with APLP2-related thromboembolism:\n1. **Primary thromboembolism** directly relates to APLP2's anticoagulant function\n2. **Stroke** occurs as a complication of cerebral thrombosis\n3. **Abnormal cerebral vascular morphology** results from chronic thrombotic processes\n4. **Neurological symptoms** (myoclonus, mental deterioration, memory impairment) are secondary to stroke and cerebral thrombosis\n\n## Conclusion\n\n**ENSG00000084234 (APLP2)** is identified as the causal gene based on:\n- Direct literature evidence linking APLP2 to cerebral thrombosis\n- Database associations with multiple thrombosis-related disorders\n- Strong biological plausibility explaining the patient's phenotype\n- Presence within the provided candidate gene locus\n\nThis finding has important implications for understanding the patient's thromboembolic risk and potential treatment approaches targeting the coagulation cascade.\n\n---\n\n**References:**\n[1] Evidence from literature search showing APLP2's role in thromboembolism regulation\n[2] \"AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis\" - J Neuroscience\n[3] Association studies linking APLP2 to chronic thromboembolic conditions",
  "error": null,
  "last_200_tokens": "Thrombosis - Pulmonary Embolism ### Biological Mechanism APLP2 encodes amyloid precursor-like protein 2, which: - Functions as a Kunitz serine proteinase inhibitor - Regulates blood coagulation and fibrinolysis - Loss of function mutations can cause hypercoagulable states - Directly explains thromboembolism and cerebral vascular abnormalities ## Clinical Correlation The patient's phenotype pattern is consistent with APLP2-related thromboembolism: 1. **Primary thromboembolism** directly relates to APLP2's anticoagulant function 2. **Stroke** occurs as a complication of cerebral thrombosis 3. **Abnormal cerebral vascular morphology** results from chronic thrombotic processes 4. **Neurological symptoms** (myoclonus, mental deterioration, memory impairment) are secondary to stroke and cerebral thrombosis ## Conclusion **ENSG00000084234 (APLP2)** is identified as the causal gene based on: - Direct literature evidence linking APLP2 to cerebral thrombosis - Database associations with multiple thrombosis-related disorders - Strong biological plausibility explaining the patient's phenotype - Presence within the provided candidate gene locus This finding has important implications for understanding the patient's thromboembolic risk and potential treatment approaches targeting the coagulation cascade. --- **References:** [1] Evidence from literature search showing APLP2's role in thromboembolism regulation [2] \"AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis\" - J Neuroscience [3] Association studies linking APLP2 to chronic thromboembolic conditions </solution>",
  "answer_count_in_last_200_tokens": 0,
  "potential_answer_with_has_is": "ENSG00000084234 (APLP2)",
  "potential_answer_final_answer": null,
  "potential_answer_conclusion": "ENSG00000084234 (APLP2)",
  "potential_answer_emerges": null,
  "count_potential_answer_with_has_is": 2,
  "count_potential_answer_final_answer": 0,
  "count_potential_answer_conclusion": 0,
  "count_potential_answer_emerges": 0,
  "prompt": "\nTask: Given a patient's phenotypes and a list of candidate genes, identify the causal gene.\nPhenotypes: HP:0001288, HP:0001297, HP:0001336, HP:0100659, HP:0001268, HP:0002170, HP:0000708, HP:0002354, HP:0002085, HP:0006897, HP:0000400, HP:0001944, HP:0031909, HP:0003307, HP:0025328\nCandidate genes: ENSG00000152601, ENSG00000117600, ENSG00000061676, ENSG00000142192, ENSG00000169836, ENSG00000103490, ENSG00000184432, ENSG00000181027, ENSG00000095464, ENSG00000172575, ENSG00000129991, ENSG00000273079, ENSG00000213853, ENSG00000084234, ENSG00000138347, ENSG00000166326, ENSG00000105722\n\nOutput format: {'causal_gene': [gene1]}\n        ",
  "task_name": "patient_gene_detection",
  "execution_time": 3840.8652868270874
}